XML 58 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
Special Charges - Restructuring (Table) (Details) - USD ($)
$ in Thousands
3 Months Ended
Feb. 02, 2019
Feb. 03, 2018
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet    
Fiscal 2018 special charges $ 21,782 $ 57,318 [1]
Non-cash impairment charge 4,367 $ 0 [2]
Closure of Manufacturing Facilities    
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet    
Accrued restructuring, beginning balance 42,974  
Fiscal 2018 special charges 1,127  
Severance and other payments 0  
Non-cash impairment charge 0  
Effect of foreign currency on accrual (14)  
Accrued restructuring, ending balance 44,087  
Reduction of Operating Costs Action    
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet    
Accrued restructuring, beginning balance 5,255  
Fiscal 2018 special charges 0  
Severance and other payments (2,489)  
Non-cash impairment charge 0  
Effect of foreign currency on accrual 4  
Accrued restructuring, ending balance 2,770  
Early Retirement Action    
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet    
Accrued restructuring, beginning balance 9,897  
Fiscal 2018 special charges 0  
Severance and other payments (2,766)  
Non-cash impairment charge 0  
Effect of foreign currency on accrual 0  
Accrued restructuring, ending balance 7,131  
Reposition Action    
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet    
Accrued restructuring, beginning balance 0  
Fiscal 2018 special charges 20,655  
Severance and other payments (1,051)  
Non-cash impairment charge (4,367)  
Effect of foreign currency on accrual (2)  
Accrued restructuring, ending balance 15,235  
Accrued Liabilities, Current [Member] | Closure of Manufacturing Facilities    
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet    
Accrued restructuring, ending balance 0  
Accrued Liabilities, Current [Member] | Reduction of Operating Costs Action    
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet    
Accrued restructuring, ending balance 2,770  
Accrued Liabilities, Current [Member] | Early Retirement Action    
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet    
Accrued restructuring, ending balance 7,131  
Accrued Liabilities, Current [Member] | Reposition Action    
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet    
Accrued restructuring, ending balance 15,235  
Accrued Liabilities, Other Non-current [Member] | Closure of Manufacturing Facilities    
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet    
Accrued restructuring, ending balance 44,087  
Accrued Liabilities, Other Non-current [Member] | Reduction of Operating Costs Action    
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet    
Accrued restructuring, ending balance 0  
Accrued Liabilities, Other Non-current [Member] | Early Retirement Action    
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet    
Accrued restructuring, ending balance 0  
Accrued Liabilities, Other Non-current [Member] | Reposition Action    
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet    
Accrued restructuring, ending balance $ 0  
[1] Balances have been restated to reflect the full retrospective adoption of Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers (ASU 2014-09). See Note 1, Basis of Presentation, in the Notes to Condensed Consolidated Financial Statements.
[2] Balances have been restated to reflect the full retrospective adoption of Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers (ASU 2014-09). See Note 1, Basis of Presentation, in the Notes to Condensed Consolidated Financial Statements.